Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic.

Scientific Reports
Sergi ValeroAgustín Ruíz

Abstract

To date, very few studies have been focused on the impact of the convergence of neuropsychiatric symptoms (NPS) and APOE ε4 on the conversion to dementia in patients with Mild Cognitive Impairment patients (MCI), and none has been based in a clinical setting. The objective of the study is to determine the predictive value of additive and multiplicative interactions of NPS and APOE ε4 status on the prediction of incident dementia among MCI patients monitored in a Memory Clinic. 1512 patients (aged 60 and older) with prevalent MCI were followed for a mean of 2 years. Neuropsychiatric symptoms were assessed at baseline using the Neuropsychiatric Inventory Questionnaire. Cox proportional hazards models were calculated. Additive interactions for depression, apathy, anxiety, agitation, appetite, or irritability and a positive ε4 carrier status were obtained, significantly increasing the hazard ratios of incident dementia (HR range 1.3-2.03). Synergistic interactions between NPS and APOE ε4 are identified among MCI patients when predicting incident dementia. The combination of the behavioral status and the genetic trait could be considered a useful strategy to identify the most vulnerable MCI patients to dementia conversion in a Memor...Continue Reading

References

Mar 20, 1999·Genetic Analysis : Biomolecular Engineering·K J Livak
Sep 23, 2000·The Journal of Neuropsychiatry and Clinical Neurosciences·D I KauferS T DeKosky
Mar 9, 2004·Journal of Alzheimer's Disease : JAD·Alexandre de MendonçaCarlos Garcia
Aug 25, 2004·Journal of Internal Medicine·R C Petersen
Aug 27, 2005·European Journal of Epidemiology·Tomas AnderssonAnders Ahlbom
Jul 4, 2007·International Journal of Geriatric Psychiatry·Martin SteinbergUNKNOWN Cache County Investigators
Nov 7, 2007·Neuropsychology·Arto NordlundAnders Wallin
Dec 19, 2007·Dementia and Geriatric Cognitive Disorders·Liana G Apostolova, Jeffrey L Cummings
Nov 27, 2008·Epidemiology·Mirjam J KnolJan P Vandenbroucke
Feb 17, 2010·Journal of Alzheimer's Disease : JAD·Mary Ann DeMichele-Sweet, Robert A Sweet
Feb 24, 2011·European Journal of Epidemiology·Mirjam J KnolDiederick E Grobbee
Aug 4, 2011·Brain : a Journal of Neurology·Katya RascovskyBruce L Miller
Dec 14, 2011·Journal of Clinical and Experimental Neuropsychology·Montserrat AlegretMercè Boada
Apr 9, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Yonas E GedaUNKNOWN Neuropsychiatric Syndromes Professional Interest Area of ISTAART
Apr 10, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Paul B RosenbergConstantine G Lyketsos
Sep 17, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Mercè BoadaUNKNOWN Fundació ACE Alzheimer Research Center and Memory Clinic
Mar 19, 2014·Alzheimer Disease and Associated Disorders·Perminder SachdevUNKNOWN Internationlal Society for Vascular Behavioral and Cognitive Disorders
Jun 7, 2015·Molecular Aspects of Medicine·Paul B RosenbergConstantine G Lyketsos
Oct 1, 2008·Dementia & Neuropsychologia·Fernando E TaraganoConstantine Lyketsos
Oct 3, 2018·International Journal of Geriatric Psychiatry·Alyssa N De VitoUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Nov 19, 2019·Neurobiology of Aging·Maurits JohanssonOskar Hansson
Sep 11, 2020·Psychiatry and Clinical Neurosciences·Mei-Feng HuangJong-Ling Fuh

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
Genotyping

Software Mentioned

STATA
comp
ACE
MedComorb
FamMedHist

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.